AI can design thousands of antibody candidates. Only a few will ever make it to the clinic.
At the AIDDD Summit in Boston, ProBio will discuss how integrated screening, validation, and CMC strategies can help transform AI-generated candidates into IND-ready programs faster and with greater confidence.